IPP Bureau
Roche retains its sustainability ranking in the Dow Jones Sustainability Indices
By IPP Bureau - November 15, 2021
The company performed particularly well in operational eco-efficiency, environmental and social reporting
Sparsh opens super speciality hospital for women and children in Bangalore
By IPP Bureau - November 15, 2021
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
European Commission approves Celltrion’s Covid-19 medicine
By IPP Bureau - November 15, 2021
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
Tripura CM inaugurates advanced imaging facility at Niramay Health centre
By IPP Bureau - November 15, 2021
Carestream equipment is highly recommended for its imaging quality
Jubilant HollisterStier plans US $92 mn expansion
By IPP Bureau - November 13, 2021
The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%
Moderna presents data from Phase 1 study of mRNA Triplet programme
By IPP Bureau - November 13, 2021
The interim data combines three mRNAs into one therapy injected directly into the tumour
Thermo Fisher to set up manufacturing facility in Mebane N.C.
By IPP Bureau - November 13, 2021
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
By IPP Bureau - November 13, 2021
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
DawaDost rolls out diabetes medicine at Re 1 per day
By IPP Bureau - November 13, 2021
The start-up has announced the scheme to mark World Diabetes Day
Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
By IPP Bureau - November 12, 2021
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Meridian Bioscience receives U.S. FDA Emergency Use Authorization for Revogene SARS-CoV-2 molecular assay
By IPP Bureau - November 12, 2021
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
World’s first Whole Genome Sequencing study uncovers new and potential therapies
By IPP Bureau - November 12, 2021
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
By IPP Bureau - November 12, 2021
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Jubilant Biosys expands Chemistry Innovation Research Centre
By IPP Bureau - November 12, 2021
The centre has an initial capacity of 500 FTEs
Sun Pharma to introduce molnupiravir in India
By IPP Bureau - November 12, 2021
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
